Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.20 -0.21 (-6.14%)
As of: Oct 21, 2026 · 3:59 PM EDT

Apimeds Pharmaceuticals US (APUS) Payables (2023 - 2026)

Updated

Apimeds Pharmaceuticals US's Payables was $12.13 million in Q2 2026, compared with $119,138 a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Payables (2023 - 2026) Analysis & Trends

At the end of FY2025, Payables at Apimeds Pharmaceuticals US came in at $8.01 million, up 852.2% from FY2024.

  • In earlier years, Payables was $841,191 in FY2024 (+161.8%) and $321,329 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 20.92 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 33.30 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.96 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 22.89 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 674.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 7.03 Bn
10 Apimeds Pharmaceuticals US 5.44 Mn -14.20 Mn - 12.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.13 Mn
Dec 31, 2025 8.01 Mn
Sep 30, 2025 567,633.00
Jun 30, 2025 119,138.00
Mar 31, 2025 1.31 Mn
Dec 31, 2024 841,191.00
Dec 31, 2023 321,329.00
API Access

Apimeds Pharmaceuticals US Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=APUS&period=max&api_key=YOUR_API_KEY